India top court to deliver key drug patent ruling | Bangkok Post: news

News > Asia

India top court to deliver key drug patent ruling

- +

India's Supreme Court is set to rule Monday on a patent challenge by Swiss drug giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in developing nations. 

Indian protesters hold placards during a demonstration against Swiss drug manufacturer Novartis, outside their offices in Mumbai on December 21, 2012. India's top court is set to rule Monday on a patent challenge by Swiss pharmaceutical giant Novartis that activists say threatens access to cheap generic versions of life-saving drugs in poor nations.

The landmark case -- watched closely by global drug firms and patient groups -- involves an updated version of Novartis' blockbuster cancer drug Glivec, for which the company has fought a seven-year legal battle to win patent protection.

This article is older than 60 days, which we reserve for our premium members only.You can subscribe to our premium member subscription, here.

0 people commented about the above

Readers are urged not to submit comments that may cause legal dispute including slanderous, vulgar or violent language, incorrectly spelt names, discuss moderation action, quotes with no source or anything deemed critical of the monarchy. More information in our terms of use.

Please use our forum for more candid, lengthy, conversational and open discussion between one another.

  • Latest
  • Oldest
  • Most replied to
  • Most liked
  • Most disliked

    Click here to view more comments